Deadline to Claim Your Payout from the $10.5M ImmunityBio Settlement Is in 1 Month

Court: S.D. California

Case: 23-CV-01216

Investors have only 1 month left to submit their claims and receive payout from the $10.5M ImmunityBio settlement.

What is this settlement?

On May 11, 2023, ImmunityBio disclosed that the FDA issued a complete response letter for its Biologics License Application for Anktiva, citing issues with third-party manufacturers.

Following this news, IBRX dropped over 55%.

What can you do to recover your losses now?

You can submit your claim and be notified of any further updates.

More than 100 companies are currently paying out settlements. Connect your brokerage account to automatically check which ones you may have missed.